跳至主要内容
临床试验/EUCTR2005-004641-34-GB
EUCTR2005-004641-34-GB进行中(未招募)不适用

Human Clinical Study: Assessment of Zicam Cold Remedy RapidMelts

Matrixx Initiatives Inc0 个研究点目标入组 200 人开始时间: 2005年12月5日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Onset of common cold symptoms within 24 hours preceding pre-enrolment screening.Male and female volunteers 18 years of age and above.In good general health other than the common cold.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Cold symptoms for more than 24 hours at time of enrolment.History of perennial allergic rhinitis, asthma or any other chronic respiratory disease.Prior history of adverse reaction to zinc, calcium or any of the inactive ingredients of Zicam RapidMelts tablets.

研究者

相似试验